Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

EU watchdog disagrees with negative view on UniQure gene therapy

(Reuters) – European regulators do not agree with the negative view expressed by one adviser about the efficacy of UniQure’s drug Glybera, the Western world’s first gene therapy. The Dutch company said it had received a final assessment report from the European Medicines Agency’s Committee for Advanced Therapies (CAT) following doubts raised by the adviser, […]

Read More »

Celebrities Tweet Their Support of Melanoma Awareness Month and #newfamilyrule

Video Urges Parents to Adopt Sun Protection as Prevention TORONTO, May 6, 2015 /CNW/ – Celebrities, bloggers and influencers across North America have taken to social media to spread the important message that melanoma prevention begins with parents-encouraging everyone to create a #newfamilyrule around sun protection. Maria Sharapova, Hilary Duff, and parenting author Alyson Schafer are […]

Read More »

The Cancer Drug Market Just Hit $100 Billion And Could Jump 50% In Four Years

The global market for cancer drugs has hit $100 billion in annual sales, and could reach $147 billion by 2018, according to a new report by the IMS Institute for Healthcare Informatics, a unit of drug data provider IMS Health. This figure does not include discounts or rebates paid to insurers and government programs; IMS […]

Read More »

Global cancer drug spending hits $100 billion in 2014: IMS Health

(Reuters) – Worldwide spending on cancer medicines reached $100 billion in 2014, an increase of 10.3 percent from 2013 and up from $75 billion five years earlier, according to IMS Health’s Global Oncology Trend Report released on Tuesday. The $100 billion, which represents 10.8 percent of all drug spending globally and includes supportive care drugs […]

Read More »

China to stop setting most medicine prices from June 1

(Reuters) – China will remove price caps for most medicines from June 1 and give the market a larger role in setting prices in the world’s second largest pharmaceutical market, the country’s economic planning agency said on Tuesday. The change would encourage “reasonable” pricing of medicines and help control costs in the country’s state medical […]

Read More »

Creators Of Sunscreen Mist Promote Safe Sun Protection Throughout Skin Cancer Awareness Month

DETROIT, May 4, 2015 /PRNewswire/ — In recognition of Skin Cancer Awareness Month and Melanoma Monday, the creators of Michigan-based Sunscreen Mist, the world leader of automated patented sunscreen-spray stations and booths, remind consumers about the importance of diligent sun protection in promoting health. Sunscreen Mist will appear on ABC’s “Shark Tank” on Friday, May 8 […]

Read More »

Merkle’s Health Practice Grew Over 20% in 2014

COLUMBIA, Md.–(BUSINESS WIRE)–Merkle, ( a leading technology-enabled, data-driven performance marketing agency, announced significant growth in its health practice, with the company landing 15th on Advertising Age’s largest U.S. healthcare agency networks and the 3rd fastest growing in the country. The impressive 21 percent year-over-year growth for Merkle Health demonstrates the success Merkle has had in […]

Read More »

Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition

ALISO VIEJO, Calif., May 1, 2015 /PRNewswire/ — Legendary actor and director Danny Glover joins Avanir Pharmaceuticals, Inc. in a new PBAFacts campaign designed to educate and encourage patients with neurologic conditions, and their caregivers, to learn more about Pseudobulbar Affect (PBA) and to speak with their physician. The campaign hinges on the idea that an […]

Read More »

New Study Examines Success Lessons of Sovaldi’s and Harvoni’s Blockbuster Launches

CHAPEL HILL, N.C., May 1, 2015 /PRNewswire/ — The breakthrough hepatitis C treatment, Sovaldi faced backlash from payers for its high price but manufacturer Gilead Sciences overcame initial market resistance through its patient support programs, strategic worldwide pricing, and effective public relations campaigns. Sovaldi’s high cure rate, short dosing period, and promise of less severe […]

Read More »

Mallinckrodt Pharmaceuticals Becomes First-Ever National Sponsor of the Lupus Foundation of America’s Walk to End Lupus Now

WASHINGTON, DC–(Marketwired – May 01, 2015) – Mallinckrodt Pharmaceuticals (NYSE: MNK) will join the Lupus Foundation of America in its efforts to end the cruel mystery of lupus by sponsoring its signature program, Walk to End Lupus Now™. Walk events take place in more than 60 cities across the country, making it the nation’s largest lupus […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2019 Focus: Top 50 Company Profiles & Financials, Outcomes Creativity Index, and more!


Ad Right Bottom